文献速递浆细胞疾病

ABL1激酶在多发性骨髓瘤自发性和化疗诱导的基因组不稳定性中起重要作用

ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.
PubMed 文献 · Blood · 2024-01-01

本研究显示多发性骨髓瘤(MM)细胞中ABL1激酶水平升高过度激活同源重组(HR)通路并导致基因组不稳定性;用短发夹RNA或尼洛替尼抑制ABL1可抑制HR活性、减少基因组不稳定性并减缓MM细胞生长;在皮下肿瘤模型中,抑制ABL1可降低美法仑引起的HR活性和基因组不稳定性,并增强美法仑的疗效和细胞毒性。

要点

  • MM细胞中ABL1激酶升高过度激活HR通路并导致基因组不稳定性。
  • 短发夹RNA或尼洛替尼抑制ABL1可抑制HR活性、减少基因组不稳定性并减缓MM细胞生长。
  • 在皮下肿瘤模型中,抑制ABL1降低美法仑引起的HR活性和基因组不稳定性,并增强美法仑疗效和细胞毒性。

核心结论

  • 使用临床已批准药物尼洛替尼抑制ABL1可减少MM细胞生长、减少活细胞组分中的基因组不稳定性、增加美法仑(及类似化疗药)的细胞毒性,并可能预防或延缓MM患者进展。

研究设计与样本

  • 研究在MM细胞中检测ABL1激酶水平升高对HR通路和基因组不稳定性的影响,并用短发夹RNA或尼洛替尼抑制ABL1。
  • 在皮下肿瘤模型中评估抑制ABL1对美法仑所致HR活性、基因组不稳定性和疗效的影响。

主要发现

  • MM细胞中ABL1激酶水平升高过度激活HR通路并导致基因组不稳定性。
  • 用短发夹RNA或尼洛替尼抑制ABL1可抑制HR活性、减少基因组不稳定性并减缓MM细胞生长。
  • 抑制ABL1可降低美法仑引起的HR活性和基因组不稳定性,并增强美法仑在皮下肿瘤模型中的疗效和细胞毒性。
  • 在皮下肿瘤中,尼洛替尼抑制内源性以及美法仑诱导的HR活性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genomic instability contributes to cancer progression and is at least partly due to dysregulated homologous recombination (HR). Here, we show that an elevated level of ABL1 kinase overactivates the HR pathway and causes genomic instability in multiple myeloma (MM) cells. Inhibiting ABL1 with either short hairpin RNA or a pharmacological inhibitor (nilotinib) inhibits HR activity, reduces genomic instability, and slows MM cell growth. Moreover, inhibiting ABL1 reduces the HR activity and genomic instability caused by melphalan, a chemotherapeutic agent used in MM treatment, and increases melphalan's efficacy and cytotoxicity in vivo in a subcutaneous tumor model. In these tumors, nilotinib inhibits endogenous as well as melphalan-induced HR activity. These data demonstrate that inhibiting ABL1 using the clinically approved drug nilotinib reduces MM cell growth, reduces genomic instability in live cell fraction, increases the cytotoxicity of melphalan (and similar chemotherapeutic agents), and can potentially prevent or delay progression in patients with MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kumar S, Talluri S, Zhao J, et al. ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma. Blood. 2024. PMID: 37992230. doi:10.1182/blood.2023021225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。